Work

Reply to “Adequate Design of Pharmacokinetic-Pharmacodynamic Studies Will Help Optimize Tuberculosis Treatment for the Future”

Year: 2015

Type: letter

Abstract: We thank Sturkenboom et al. ([1][1]) for their interest in our study and [their comments][2]. The pragmatic study design based on two sampling points, 2 and 6 h after drug intake, reflected the real-world approach taken in this study, sampling patients attending a government clinic rather than in

Source: Antimicrobial Agents and Chemotherapy

DOI: 10.1128/aac.05182-14

Authors: Ana Requena-Méndez, Geraint Davies, David A. J. Moore

Institutions: Universidad Peruana Cayetano Heredia, Barcelona Institute for Global Health, Universitat de Barcelona, University of Liverpool, London School of Hygiene & Tropical Medicine

Language: English

Topic: Tuberculosis Research and Epidemiology

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2009852657

Cites: 6

Cited by:

Related to: 10